Microwave technology saves diabetic patient from double amputation

A 74-year-old diabetic man, Barry Mayled, has successfully avoided double leg amputation thanks to a new microwave treatment called Swift, developed by the Stirling-based company Emblation. Mayled, who has type two diabetes, experienced worsening foot ulcers during the Covid pandemic, leading surgeons to consider amputation. A medical student suggested microwave treatment, which led to a series of seven applications of the Swift technology on his feet. This treatment uses low energy doses of microwaves to stimulate the immune system and promote healing. After nine months of treatment, Mayled reported that he is now "totally clear" of ulcers and able to continue his work as an architect and gardener. He expressed gratitude for the treatment, stating it saved his life and career. Tracey Davies, a podiatrist who administered the treatment, noted that Mayled's case highlights the potential of Swift in treating non-healing foot ulcers, which could prevent unnecessary amputations. The Swift device, developed in 2016, has been used globally for various conditions, and its success in Mayled's case is seen as a significant advancement in diabetic care. Emblation's CEO described the technology as "game-changing," emphasizing its potential impact on the treatment of foot ulcerations.